Search results
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 4 days agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 1 day agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
GSK faces whistleblower lawsuit over Zantac cancer risk | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 6 days agoGSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding...
Independent Advisor Alliance Has $740,000 Position in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 5 days agoIndependent Advisor Alliance decreased its position in GSK plc (NYSE:GSK – Free Report) by 8.9% in the 4th quarter, according to the company in its most ...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
GSK’s asthma drug shows promise in reducing severe attacks
WHTC 1450 Holland· 5 days ago(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals,GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 1 day agoEquity Research analysts discuss the latest news and events impacting stocks and the financial...
...Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer...
Benzinga via Yahoo Finance· 1 day agoThe jury in Cook County, Illinois, found that Angela Valadez, an 89-year-old Illinois resident, did...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 4 days agoHEALTH NEWS GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Market Watch· 5 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than...